Next Oncology

Clinical research site in Irving, Texas · 7415 LAS COLINAS BLVD STE 100, IRVING, TX 75063-7569 · (561) 408-7937

As of July 2026, 12 paid clinical trials are recruiting at Next Oncology in Irving, Texas. Active studies at this site cover conditions such as Advanced-stage Solid Tumors and Cervical Adenocarcinoma. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: July 19, 2026.

Recruiting clinical trials at Next Oncology (12)

A Study to Evaluate Efficacy and Safety of Giredestrant Compared With Fulvestrant (Plus a CDK4/6 Inhibitor), in Participants With ER-Positive, HER2-Negative Advanced Breast Cancer Resistant to Adjuvant Endocrine Therapy (pionERA Breast Cancer)

for Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer

54 locations incl. Daphne

Sponsor: Hoffmann-La Roche

Sex: All·Age: 18+

Code: NCT06065748·Phase 3·Recruiting·Listed Oct 2023

Apply to this trial

A Study Comparing the Efficacy and Safety of Zanidatamab to Trastuzumab, Each in Combination With Physician's Choice Chemotherapy, for the Treatment of Participants With Metastatic HER2-positive Breast Cancer

for Metastatic HER2-positive Breast Cancer

45 locations incl. Phoenix

Sponsor: Jazz Pharmaceuticals

Sex: All·Age: 18+

Code: NCT06435429·Phase 3·Recruiting·Listed May 2024

Apply to this trial

A Phase 1 Study of IM-1021 in Participants With Advanced Cancer

for Solid Malignancies

17 locations incl. Duarte

Sponsor: Immunome, Inc.

Sex: All·Age: 18+

Code: NCT06823167·Phase 1·Recruiting·Listed Feb 2025

Apply to this trial

A First-in-human Study of PRTH-101 Monotherapy +/- Pembrolizumab in Subjects With Advanced Malignancies

for Advanced or Metastatic Solid Tumors

10 locations incl. Scottsdale

Sponsor: Incendia Therapeutics

Sex: All·Age: 18+

Code: NCT05753722·Phase 1·Recruiting·Listed Mar 2023

Apply to this trial

Safety, PK, and Preliminary Efficacy of MBRC-101 in Advanced Refractory Solid Tumors

for Cancer

15 locations incl. San Francisco

Sponsor: MBrace Therapeutics

Sex: All·Age: 18+

Code: NCT06014658·Phase 1, Phase 2·Recruiting·Listed Aug 2023

Apply to this trial

A 2-part Phase 1/2 Open-label Trial on ODM-212

for Mesothelioma

2 locations incl. Irving

Sponsor: Orion Corporation, Orion Pharma

Sex: All·Age: 18+

Code: NCT07563738·Phase 1, Phase 2·Recruiting·Listed May 2026

Apply to this trial

AVA6103 in Subjects With Locally Advanced or Metastatic Selected Solid Tumors

for Vulvar Adenocarcinoma

3 locations incl. Grand Rapids

Sponsor: Avacta Life Sciences Ltd

Sex: All·Age: 18+

Code: NCT07454642·Phase 1·Recruiting·Listed Mar 2026

Apply to this trial

A Clinical Study of MK-4716 in People With Certain Solid Tumors (MK-4716-001)

for Malignant Neoplasm

3 locations incl. New Brunswick

Sponsor: Merck Sharp & Dohme LLC

Sex: All·Age: 18+

Code: NCT07247110·Phase 1·Recruiting·Listed Nov 2025

Apply to this trial

A Study of JNJ-89862175 for Treatment of Advanced Solid Tumors

for Advanced-stage Solid Tumors

2 locations incl. Orlando

Sponsor: Janssen Research & Development, LLC

Sex: All·Age: 18+

Code: NCT07223125·Phase 1·Recruiting·Listed Oct 2025

Apply to this trial

A Study to Evaluate the Safety and Efficacy of MK-3120 in Participants With Advanced Solid Tumors (MK-3120-002)

for Advanced Solid Tumors

7 locations incl. Birmingham

Sponsor: Merck Sharp & Dohme LLC

Sex: All·Age: 18+

Code: NCT06818643·Phase 1, Phase 2·Recruiting·Listed Feb 2025

Apply to this trial

A Study of ERAS-4001 in Patients With Advanced or Metastatic Solid Tumors.

for Metastatic Solid Tumors

5 locations incl. Nashville

Sponsor: Erasca, Inc.

Sex: All·Age: 18 - 99

Code: NCT07021898·Phase 1·Recruiting·Listed Jun 2025

Apply to this trial

Safety, Tolerability, and Pharmacokinetics of DCR-PDL1 in Adults With Solid Tumors

for Solid Tumors, Adult

2 locations incl. Irving

Sponsor: Dicerna Pharmaceuticals, Inc., a Novo Nordisk company

Sex: All·Age: 18+

Code: NCT06504368·Phase 1·Recruiting·Listed Jul 2024

Apply to this trial

More research sites in Irving

NEXT Dallas (18 trials)
NEXT Oncology Dallas (9 trials)
US Oncology Investigational Product Center (IPC) (8 trials)
US Oncology Investigational Products Center (IPC) (8 trials)
NEXT Oncology - Dallas (7 trials)
US Oncology Investigational Products Center (4 trials)
Texas Center for Proton Therapy (3 trials)
US Oncology Research Investigational Products Center (3 trials)
NEXT Dallas - Oncology Department (2 trials)
Precision Comprehensive Clinical Research Solutions (2 trials)

Explore more

Paid clinical trials in Irving, TX · Texas clinical trials